Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

The Dark Report

“September 28, 1998 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / By Robert Michel

Just days ago, Bayer AG announced one of the largest drug-discovery alliances ever created. Bayer will pay Millennium Pharmaceuticals, Inc. $465 million. In return, over a six-year period, Millennium will use genomics techniques to identify cures for various diseases. Millennium must deliver 225 drug “targets” or proteins that may be useful in designing drugs. MORE …

“September 28, 1998 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Unilab’s Bid To Buy Meris Will Shake Up California

Laboratory Management / By Robert Michel

CEO SUMMARY: More laboratory overcapacity may be removed from the California marketplace if Unilab purchases Meris Laboratories. Unilab’s offer to buy Meris must be cleared by the bankruptcy court and other bidders may surface during the coming weeks. These events are a reminder that financial pressure on the clinical laboratory industry continues to force change …

Unilab’s Bid To Buy Meris Will Shake Up California Read More »

To access this post, you must purchase The Dark Report.

AutoCyte Moves One Step Closer To FDA Approval

Laboratory Automation / By Robert Michel

CEO SUMMARY: Until now, AutoCyte has kept a relatively quiet presence in the automated cytology marketplace. That may soon change as the FDA takes action on the company’s PREP™ and SCREEN™ products. AutoCyte expects these products will boost productivity and quality in cytology labs. AutoCyte’s product positioning will be very different than its competitors: NeoPath, …

AutoCyte Moves One Step Closer To FDA Approval Read More »

To access this post, you must purchase The Dark Report.

Bayer Acquires Chiron In Consolidation Move

In Vitro Diagnostics / By Robert Michel

CEO SUMMARY: As expected, consolidation within the diagnostics industry continues. This time it is Bayer, spending $1.1 billion to acquire Chiron’s diagnostics business. Once completed, Bayer will be the fourth-largest diagnostics company in the world. Laboratory customers of both firms will see many changes during the 18 months following the merger. ONCE AGAIN THE DIAGNOSTICS …

Bayer Acquires Chiron In Consolidation Move Read More »

To access this post, you must purchase The Dark Report.

Chiron Is Biotech Firm, Respected For Innovation

In Vitro Diagnostics / By Robert Michel

CEO SUMMARY: Chiron is respected for its leadership in branched DNA and viral load technologies. The company had high expectations for its diagnostics group, particularly after its purchase of Ciba Corning. But rapid consolidation of the diagnostics industry changed Chiron’s opportunity to reach the first tier of diagnostic companies. Its experience demonstrates the far-reaching impact …

Chiron Is Biotech Firm, Respected For Innovation Read More »

To access this post, you must purchase The Dark Report.

Pathologists Will Learn Income-Boosting Methods

Pathology Trends / By Robert Michel

CEO SUMMARY: Reimbursement for pathology services continues to decline. Despite this fact, savvy pathologists throughout the country are steadily increasing their take-home income. Their proven methods and secret strategies will be the theme of the Private Pathology Income Symposium. This year’s event will teach participating pathologists how to preserve and enhance their practice income. REIMBURSEMENT …

Pathologists Will Learn Income-Boosting Methods Read More »

To access this post, you must purchase The Dark Report.

Pathologists, Clin Labs, Pharmacogenomics & PPMs

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

AT MY AGE, I AM LEARNING THAT PEOPLE TEND TO HOLD ONE OF TWO OPINIONS about me. It seems that I can frequently be considered a doddering old fool who is totally unhip (although I recall an even earlier generation calling it “unhep”). On the other hand, there are those who grant me great respect. …

Pathologists, Clin Labs, Pharmacogenomics & PPMs Read More »

To access this post, you must purchase The Dark Report.

September 8, 1998 Intelligence: Late Breaking Lab News

Late Breaking Lab News / By Robert Michel

If any one individual was to be credited with creating the modern commercial laboratory organization, it would be Paul Brown, M.D., founder and former Chairman of MetPath, Inc. (now Quest Diagnostics Incorporated). Where is he now? For ten years, he served as a Director for UroCor, Inc. of Oklahoma City. Dr. Brown recently resigned from …

September 8, 1998 Intelligence: Late Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

DIANON Shoots At Urocor, Makes Unwelcome Offer

Laboratory Management / By Robert Michel

CEO SUMMARY: It pays to know your friends. Last month DIANON Systems announced an unsolicited offer to acquire UroCor. The offer, following months of ongoing discussions between the two companies, was clearly unwelcome at UroCor. Both companies are pushing hard to evolve disease management products from diagnostics testing and compete nationally for urologist referrals ON …

DIANON Shoots At Urocor, Makes Unwelcome Offer Read More »

To access this post, you must purchase The Dark Report.

Veterans Administration Network Restructures Using Partnering, Telepathology

Laboratory Management / By Robert Michel

CEO SUMMARY: Economic pressures are forcing even the traditional and staid Veterans Administration to extensively reconfigure its laboratory services. At this year’s Executive War College in New Orleans, participants learned how one eight-hospital VA region consolidated testing around two core labs, entered into a partnership with a commercial laboratory, and used telepathology to serve a …

Veterans Administration Network Restructures Using Partnering, Telepathology Read More »

To access this post, you must purchase The Dark Report.

;